RuxolitinibVarious toxicities following off-label use: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1810卷 / 1期

关键词：

D O I：

10.1007/s40278-020-80205-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：185 / 185

相关论文

共 50 条

[41] BaricitinibVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2022, 1933 (1) : 111 - 111
[42] AdalimumabVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2018, 1718 (1) : 14 - 14
[43] DexmedetomidineVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2020, 1786 (1) : 75 - 75
[44] AnakinraVarious toxicities following off-label use: 16 case reports
Reactions Weekly, 2015, 1546 (1) : 25 - 25
[45] DiminazeneVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2023, 1984 (1) : 201 - 201
[46] AtropineVarious toxicities following off-label use: 2 case reports
Reactions Weekly, 2019, 1766 (1) : 66 - 66
[47] Ciclosporin/ruxolitinibVarious toxicities, lack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1889 (1) : 111 - 111
[48] Multiple drugsVarious toxicities and off-label use: 6 case reports
Reactions Weekly, 2022, 1925 (1) : 386 - 386
[49] Liraglutide/semaglutideVarious toxicities and off-label use: 6 case reports
Reactions Weekly, 2024, 2026 (1) : 174 - 174
[50] DisulfiramVarious toxicities and no improvement following off-label use: 47 case reports
Reactions Weekly, 2021, 1873 (1) : 104 - 104

← 1 2 3 4 5 →